「ca」の検索結果
161件：41～45件目を表示
-
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7...
http://www.senju.co.jp/english/news/ -
Quality Policies | About Senju | SENJU Pharmaceutical
ways pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standards on product quality, and exercise...
http://www.senju.co.jp/english/about/quality.html -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
General Announcement: June 1, 2026 Senju Pharmaceutical Co., Ltd. Launch of Distribution of 3in1Smart and SPM-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yosh...
https://www.senju.co.jp/system/files/content_news/2026-05/ENG_20260601.pdf -
ピマリシン点眼液5%「センジュ」
oxy-12-methyl- 10-oxo-6, 11, 28-trioxatricyclo[22.3.1.05,7 ]octacosa- 8, 14, 16, 18, 20-pentaene-25-carboxylic acid 構造式： 分子式：C33H47NO13 分子量：665.73 性 状：ピマリシンは白色∼黄白色の結晶性の 末である。 メタノール又は酢酸 （100） に溶けにくく、水又...
https://www.senju.co.jp/system/files/product_other_file/2023-06/pimaricin-5_202307_C1.pdf